580 related articles for article (PubMed ID: 24201391)
1. Incidence, prognosis, and treatment options for patients with synchronous peritoneal carcinomatosis and liver metastases from colorectal origin.
Thomassen I; van Gestel YR; Lemmens VE; de Hingh IH
Dis Colon Rectum; 2013 Dec; 56(12):1373-80. PubMed ID: 24201391
[TBL] [Abstract][Full Text] [Related]
2. Is unexpected peritoneal carcinomatosis still a contraindication for resection of colorectal liver metastases? Combined resection of colorectal liver metastases with peritoneal deposits discovered intra-operatively.
Allard MA; Adam R; Ruiz A; Vibert E; Paule B; Levi F; Sebagh M; Guettier C; Azoulay D; Castaing D
Eur J Surg Oncol; 2013 Sep; 39(9):981-7. PubMed ID: 23845705
[TBL] [Abstract][Full Text] [Related]
3. Should patients with peritoneal carcinomatosis of colorectal origin with synchronous liver metastases be treated with a curative intent? A case-control study.
Maggiori L; Goéré D; Viana B; Tzanis D; Dumont F; Honoré C; Eveno C; Elias D
Ann Surg; 2013 Jul; 258(1):116-21. PubMed ID: 23207243
[TBL] [Abstract][Full Text] [Related]
4. Peritoneal carcinomatosis and liver metastases from colorectal cancer treated with cytoreductive surgery perioperative intraperitoneal chemotherapy and liver resection.
Chua TC; Yan TD; Zhao J; Morris DL
Eur J Surg Oncol; 2009 Dec; 35(12):1299-305. PubMed ID: 19632081
[TBL] [Abstract][Full Text] [Related]
5. Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancer.
van Gestel YR; Thomassen I; Lemmens VE; Pruijt JF; van Herk-Sukel MP; Rutten HJ; Creemers GJ; de Hingh IH
Eur J Surg Oncol; 2014 Aug; 40(8):963-9. PubMed ID: 24183168
[TBL] [Abstract][Full Text] [Related]
6. Analysis of prognostic factors in seventy patients having a complete cytoreduction plus perioperative intraperitoneal chemotherapy for carcinomatosis from colorectal cancer.
da Silva RG; Sugarbaker PH
J Am Coll Surg; 2006 Dec; 203(6):878-86. PubMed ID: 17116556
[TBL] [Abstract][Full Text] [Related]
7. Epidemiology, Management, and Survival of Peritoneal Carcinomatosis from Colorectal Cancer: A Population-Based Study.
Quere P; Facy O; Manfredi S; Jooste V; Faivre J; Lepage C; Bouvier AM
Dis Colon Rectum; 2015 Aug; 58(8):743-52. PubMed ID: 26163953
[TBL] [Abstract][Full Text] [Related]
8. Outcome of surgery for colorectal cancer in the presence of peritoneal carcinomatosis.
Klaver YL; Lemmens VE; de Hingh IH
Eur J Surg Oncol; 2013 Jul; 39(7):734-41. PubMed ID: 23523316
[TBL] [Abstract][Full Text] [Related]
9. Predictors and survival of synchronous peritoneal carcinomatosis of colorectal origin: a population-based study.
Lemmens VE; Klaver YL; Verwaal VJ; Rutten HJ; Coebergh JW; de Hingh IH
Int J Cancer; 2011 Jun; 128(11):2717-25. PubMed ID: 20715167
[TBL] [Abstract][Full Text] [Related]
10. Addition of biological therapies to palliative chemotherapy prolongs survival in patients with peritoneal carcinomatosis of colorectal origin.
Klaver YL; Leenders BJ; Creemers GJ; Rutten HJ; Verwaal VJ; Lemmens VE; de Hingh IH
Am J Clin Oncol; 2013 Apr; 36(2):157-61. PubMed ID: 22314003
[TBL] [Abstract][Full Text] [Related]
11. Ovarian metastasis is associated with retroperitoneal lymph node relapses in women treated for colorectal peritoneal carcinomatosis.
Eveno C; Goéré D; Dartigues P; Honoré C; Dumont F; Tzanis D; Benhaim L; Malka D; Elias D
Ann Surg Oncol; 2013 Feb; 20(2):491-6. PubMed ID: 22956066
[TBL] [Abstract][Full Text] [Related]
12. Treatment of synchronous peritoneal carcinomatosis and liver metastases from colorectal cancer.
Elias D; Benizri E; Pocard M; Ducreux M; Boige V; Lasser P
Eur J Surg Oncol; 2006 Aug; 32(6):632-6. PubMed ID: 16621428
[TBL] [Abstract][Full Text] [Related]
13. Outcomes following surgery for colorectal cancer with synchronous peritoneal metastases.
Mulsow J; Merkel S; Agaimy A; Hohenberger W
Br J Surg; 2011 Dec; 98(12):1785-91. PubMed ID: 22034185
[TBL] [Abstract][Full Text] [Related]
14. Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.
Koppe MJ; Boerman OC; Oyen WJ; Bleichrodt RP
Ann Surg; 2006 Feb; 243(2):212-22. PubMed ID: 16432354
[TBL] [Abstract][Full Text] [Related]
15. Peritoneal carcinomatosis from colorectal cancer.
Jayne DG; Fook S; Loi C; Seow-Choen F
Br J Surg; 2002 Dec; 89(12):1545-50. PubMed ID: 12445064
[TBL] [Abstract][Full Text] [Related]
16. The management of synchronous peritoneal carcinomatosis and hematogenous metastasis from colorectal cancer.
Carmignani CP; Ortega-Perez G; Sugarbaker PH
Eur J Surg Oncol; 2004 May; 30(4):391-8. PubMed ID: 15063892
[TBL] [Abstract][Full Text] [Related]
17. A multidisciplinary approach for peritoneal carcinomatosis and bilobar liver metastases from colorectal cancer: case report and review of the literature.
Ramírez-Plaza CP; Moreno-Ruiz FJ; Pérez-Daga JA
World J Surg Oncol; 2015 Aug; 13():233. PubMed ID: 26231227
[TBL] [Abstract][Full Text] [Related]
18. Management of colorectal liver metastases in patients with peritoneal carcinomatosis.
Izzo F; Piccirillo M; Palaia R; Albino V; Di Giacomo R; Mastro AA
J Surg Oncol; 2009 Sep; 100(4):345-7. PubMed ID: 19697443
[TBL] [Abstract][Full Text] [Related]
19. Incidence, prognosis, and possible treatment strategies of peritoneal carcinomatosis of pancreatic origin: a population-based study.
Thomassen I; Lemmens VE; Nienhuijs SW; Luyer MD; Klaver YL; de Hingh IH
Pancreas; 2013 Jan; 42(1):72-5. PubMed ID: 22850624
[TBL] [Abstract][Full Text] [Related]
20. The role of cytoreductive surgery alone for the treatment of peritoneal carcinomatosis of colorectal origin. A retrospective analysis with regard to multimodal treatments.
Scaringi S; Leo F; Canonico G; Batignani G; Ficari F; Tonelli F
Hepatogastroenterology; 2009; 56(91-92):650-5. PubMed ID: 19621673
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
